147 related articles for article (PubMed ID: 10895413)
1. Selective DNA release from DQAsome/DNA complexes at mitochondria-like membranes.
Weissig V; Lizano C; Torchilin VP
Drug Deliv; 2000; 7(1):1-5. PubMed ID: 10895413
[TBL] [Abstract][Full Text] [Related]
2. Mitochondriotropic cationic vesicles: a strategy towards mitochondrial gene therapy.
Weissig V; Torchilin VP
Curr Pharm Biotechnol; 2000 Dec; 1(4):325-46. PubMed ID: 11467330
[TBL] [Abstract][Full Text] [Related]
3. Cationic bolasomes with delocalized charge centers as mitochondria-specific DNA delivery systems.
Weissig V; Torchilin VP
Adv Drug Deliv Rev; 2001 Jul; 49(1-2):127-49. PubMed ID: 11377808
[TBL] [Abstract][Full Text] [Related]
4. Towards mitochondrial gene therapy: DQAsomes as a strategy.
Weissig V; Torchilin VP
J Drug Target; 2001; 9(1):1-13. PubMed ID: 11378519
[TBL] [Abstract][Full Text] [Related]
5. DQAsome-mediated delivery of plasmid DNA toward mitochondria in living cells.
D'Souza GG; Rammohan R; Cheng SM; Torchilin VP; Weissig V
J Control Release; 2003 Sep; 92(1-2):189-97. PubMed ID: 14499196
[TBL] [Abstract][Full Text] [Related]
6. DQAsomes as the Prototype of Mitochondria-Targeted Pharmaceutical Nanocarriers : An Update.
Weissig V; Lozoya M; Yu N; D'Souza GGM
Methods Mol Biol; 2021; 2275():13-25. PubMed ID: 34118029
[TBL] [Abstract][Full Text] [Related]
7. DQAsome/DNA complexes release DNA upon contact with isolated mouse liver mitochondria.
Weissig V; D'Souza GG; Torchilin VP
J Control Release; 2001 Aug; 75(3):401-8. PubMed ID: 11489326
[TBL] [Abstract][Full Text] [Related]
8. DQAsomes: a novel potential drug and gene delivery system made from Dequalinium.
Weissig V; Lasch J; Erdos G; Meyer HW; Rowe TC; Hughes J
Pharm Res; 1998 Feb; 15(2):334-7. PubMed ID: 9523323
[TBL] [Abstract][Full Text] [Related]
9. Approaches to mitochondrial gene therapy.
D'Souza GG; Weissig V
Curr Gene Ther; 2004 Sep; 4(3):317-28. PubMed ID: 15384945
[TBL] [Abstract][Full Text] [Related]
10. DQAsomes as the prototype of mitochondria-targeted pharmaceutical nanocarriers: preparation, characterization, and use.
Weissig V
Methods Mol Biol; 2015; 1265():1-11. PubMed ID: 25634263
[TBL] [Abstract][Full Text] [Related]
11. Dequalinium vesicles form stable complexes with plasmid DNA which are protected from DNase attack.
Lasch J; Meye A; Taubert H; Koelsch R; Mansa-ard J; Weissig V
Biol Chem; 1999 Jun; 380(6):647-52. PubMed ID: 10430028
[TBL] [Abstract][Full Text] [Related]
12. Design and development of novel mitochondrial targeted nanocarriers, DQAsomes for curcumin inhalation.
Zupančič Š; Kocbek P; Zariwala MG; Renshaw D; Gul MO; Elsaid Z; Taylor KM; Somavarapu S
Mol Pharm; 2014 Jul; 11(7):2334-45. PubMed ID: 24852198
[TBL] [Abstract][Full Text] [Related]
13. Mitochondrial leader sequence--plasmid DNA conjugates delivered into mammalian cells by DQAsomes co-localize with mitochondria.
D'Souza GG; Boddapati SV; Weissig V
Mitochondrion; 2005 Oct; 5(5):352-8. PubMed ID: 16154389
[TBL] [Abstract][Full Text] [Related]
14. Expression of GFP in the mitochondrial compartment using DQAsome-mediated delivery of an artificial mini-mitochondrial genome.
Lyrawati D; Trounson A; Cram D
Pharm Res; 2011 Nov; 28(11):2848-62. PubMed ID: 21833794
[TBL] [Abstract][Full Text] [Related]
15. Transferrin coupled vesicular system for intracellular drug delivery for the treatment of cancer: development and characterization.
Vaidya B; Vyas SP
J Drug Target; 2012 May; 20(4):372-80. PubMed ID: 22339366
[TBL] [Abstract][Full Text] [Related]
16. Dequalinium-Derived Nanoconstructs: A Promising Vehicle for Mitochondrial Targeting.
Pawar A; Korake S; Gajbhiye KR
Curr Drug Deliv; 2021; 18(8):1056-1063. PubMed ID: 33475059
[TBL] [Abstract][Full Text] [Related]
17. Dequalinium-based functional nanosomes show increased mitochondria targeting and anticancer effect.
Bae Y; Jung MK; Lee S; Song SJ; Mun JY; Green ES; Han J; Ko KS; Choi JS
Eur J Pharm Biopharm; 2018 Mar; 124():104-115. PubMed ID: 29305141
[TBL] [Abstract][Full Text] [Related]
18. Bolaamphiphile-based nanocomplex delivery of phosphorothioate gapmer antisense oligonucleotides as a treatment for Clostridium difficile.
Hegarty JP; Krzeminski J; Sharma AK; Guzman-Villanueva D; Weissig V; Stewart DB
Int J Nanomedicine; 2016; 11():3607-19. PubMed ID: 27536102
[TBL] [Abstract][Full Text] [Related]
19. Functional nanosome for enhanced mitochondria-targeted gene delivery and expression.
Bae Y; Jung MK; Song SJ; Green ES; Lee S; Park HS; Jeong SH; Han J; Mun JY; Ko KS; Choi JS
Mitochondrion; 2017 Nov; 37():27-40. PubMed ID: 28669809
[TBL] [Abstract][Full Text] [Related]
20. The use of mitochondrial targeting resveratrol liposomes modified with a dequalinium polyethylene glycol-distearoylphosphatidyl ethanolamine conjugate to induce apoptosis in resistant lung cancer cells.
Wang XX; Li YB; Yao HJ; Ju RJ; Zhang Y; Li RJ; Yu Y; Zhang L; Lu WL
Biomaterials; 2011 Aug; 32(24):5673-87. PubMed ID: 21550109
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
